Cholesterol-β1AR interaction versus cholesterol-β2AR interaction

Proteins: Structure, Function and Bioinformatics

Volumn 82, Issue 5, 2014, Pages 760-770

  Cang, Xiaohui ^a,b   Yang, Linlin ^a   Yang, Jing ^a   Luo, Cheng ^a   Zheng, Mingyue ^a   Yu, Kunqian ^a   Yang, Huaiyu ^a   Jiang, Hualiang ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Cholesterol binding site; G protein coupled receptor; Molecular dynamics simulation; adrenergic receptor

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CHOLESTEROL; PROTEIN BINDING;

ARTICLE; HUMAN; LIPID BILAYER; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RECEPTOR BINDING; SURFACE PROPERTY; ANIMAL; BINDING SITE; CHEMISTRY; CONSENSUS SEQUENCE; METABOLISM; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; TURKEY;

AMINO ACID MOTIFS; ANIMALS; BINDING SITES; CHOLESTEROL; CONSENSUS SEQUENCE; HUMANS; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; TURKEY;

EID: 84898045258     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.24456     Document Type: Article

References (54)

1. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 2003;63:1256-1272.
2. Schlyer S, Horuk R. I want a new drug: G-protein-coupled receptors in drug development. Drug Discov Today 2006;11:481-493.
3. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature 2002;415:206-212.
4. 2-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G protein. Circulation 1999;100:2210-2212.
5. Xiao RP, Zhu W, Zheng M, Chakir K, Bond R, Lakatta EG, Cheng H. Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci 2004;25:358-365.
6. Xiang Y, Kobilka BK. Myocyte adrenoceptor signaling pathways. Science 2003;300:1530-1532.
7. Shcherbakova OG, Hurt CM, Xiang Y, Dell'Acqua ML, Zhang Q, Tsien RW, Kobilka BK. Organization of beta-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes. J Cell Biol 2007;176:521-533.
8. Coskun U, Simons K. Cell membranes: the lipid perspective. Structure 2011;19:1543-1548.
9. Lee AG. Biological membranes: the importance of molecular detail. Trends Biochem Sci 2011;36:493-500.
10. Burger K, Gimpl G, Fahrenholz F. Regulation of receptor function by cholesterol. Cell Mol Life Sci 2000;57:1577-1592.
11. Paila YD, Chattopadhyay A. Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell Biochem 2010;51:439-466.
12. Pucadyil TJ, Chattopadhyay A. Role of cholesterol in the function and organization of G-protein coupled receptors. Prog Lipid Res 2006;45:295-333.
13. Rybin VO, Xu X, Lisanti MP, Steinberg SF. Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 2000;275:41447-41457.
14. 2-adrenergic regulation. Proc Natl Acad Sci U S A 2006;103:7500-7505.
15. Contreras FX, Ernst AM, Wieland F, Brugger B. Specificity of intramembrane protein-lipid interactions. Cold Spring Harb Perspect Biol 2011;3: a004705.
16. Lindahl E, Sansom MS. Membrane proteins: molecular dynamics simulations. Curr Opin Struct Biol 2008;18:425-431.
17. Grossfield A. Recent progress in the study of G protein-coupled receptors with molecular dynamics computer simulations. Biochim Biophys Acta 2011;1808:1868-1878.
18. Mahmood I, Liu X, Neya S, Hoshino T. Influence of lipid composition on the structural stability of G-protein coupled receptor. Chem Pharm Bull 2013;61:426-437.
19. 1A receptor: role of membrane cholesterol in ligand binding of the receptor. Mol Biosyst 2011;7:224-234.
20. 2A adenosine receptor. Structure 2009;17:1660-1668.
21. Grossfield A, Feller SE, Pitman MC. A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids. Proc Natl Acad Sci U S A 2006;103:4888-4893.
22. Bruno A, Costantino G, de Fabritiis G, Pastor M, Selent J. Membrane-sensitive conformational states of helix 8 in the metabotropic glu2 receptor, a class C GPCR. PLoS One 2012;7:e42023.
23. 2A receptor determine its activation and membrane-driven oligomerization properties. PLoS Comput Biol 2012;8:e1002473.
24. Pitman MC, Grossfield A, Suits F, Feller SE. Role of cholesterol and polyunsaturated chains in lipid-protein interactions: molecular dynamics simulation of rhodopsin in a realistic membrane environment. J Am Chem Soc 2005;127:4576-4577.
25. Khelashvili G, Grossfield A, Feller SE, Pitman MC, Weinstein H. Structural and dynamic effects of cholesterol at preferred sites of interaction with rhodopsin identified from microsecond length molecular dynamics simulations. Proteins 2009;76:403-417.
26. 2A adenosine receptor. J Am Chem Soc 2012;134:16512-16515.
27. 2-adrenergic receptor by long-time molecular dynamics simulations. J Phys Chem B 2013;117:1085-1094.
28. 1A receptor. J Phys Chem B 2012;116:12991-12996.
29. Ballesteros JA, Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci 1995;25:366-428.
30. 1-adrenergic G-protein-coupled receptor. Nature 2008;454:486-491.
31. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983;79:926-935.
32. Hess B, Kutzner C, van der Spoel D, Lindahl E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 2008;4:435-447.
33. Mackerell AD, Jr., Feig M, Brooks CL, 3rd. Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J Comput Chem 2004;25:1400-1415.
34. MacKerell AD, Bashford D, Bellott, Dunbrack RL, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, Joseph-McCarthy D, Kuchnir L, Kuczera K, Lau FTK, Mattos C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher WE, Roux B, Schlenkrich M, Smith JC, Stote R, Straub J, Watanabe M, Wiórkiewicz-Kuczera J, Yin D, Karplus M. All-Atom Empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 1998;102:3586-3616.
35. Lindahl E, Bjelkmar P, Larsson P, Cuendet MA, Hess B. Implementation of the CHARMM force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models. J Chem Theory Comput 2010;6:459-466.
36. MacKerell AD, Klauda JB, Venable RM, Freites JA, O'Connor JW, Tobias DJ, Mondragon-Ramirez C, Vorobyov I, Pastor RW. Update of the CHARMM all-atom additive force field for lipids: validation on six lpid types. J Phys Chem B 2010;114:7830-7843.
37. Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys 2007;126:014101.
38. Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR. Molecular dynamics with coupling to an external bath. J Chem Phys 1984;81:3684-3690.
39. Miyamoto S, Kollman PA. Settle - an analytical version of the shake and rattle algorithm for rigid water models. J Comput Chem 1992;13:952-962.
40. Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. LINCS: a linear constraint solver for molecular simulations. J Comput Chem 1997;18:1463-1472.
41. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh ewald potential. J Chem Phys 1995;103:8577-8592.
42. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996;14:33-38.
43. 2-adrenergic receptor. Structure 2008;16:897-905.
44. 2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. J Am Chem Soc 2010;132:11443-11445.
45. 1-adrenergic receptor. Nature 2011;469:241-244.
46. Ruprecht JJ, Mielke T, Vogel R, Villa C, Schertler GF. Electron crystallography reveals the structure of metarhodopsin I. Embo J 2004;23:3609-3620.
47. Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK, Granier S. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist. Nature 2012;485:321-326.
48. Liu W, Chun E, Thompson AA, Chubukov P, Xu F, Katritch V, Han GW, Roth CB, Heitman LH, IJzerman AP, Cherezov V, Stevens RC. Structural basis for allosteric regulation of GPCRs by sodium ions. Science 2012;337:232-236.
49. 2-adrenergic G protein-coupled receptor. Science 2007;318:1258-1265.
50. Jamin N, Neumann JM, Ostuni MA, Vu TK, Yao ZX, Murail S, Robert JC, Giatzakis C, Papadopoulos V, Lacapere JJ. Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol Endocrinol 2005;19:588-594.
51. Paila YD, Tiwari S, Chattopadhyay A. Are specific nonannular cholesterol binding sites present in G-protein coupled receptors? Biochim Biophys Acta 2009;1788:295-302.
52. Nichols DE, Nichols CD. Serotonin receptors. Chem Rev 2008;108:1614-1641.
53. Adamian L, Naveed H, Liang J. Lipid-binding surfaces of membrane proteins: evidence from evolutionary and structural analysis. Biochim Biophys Acta 2011;1808:1092-1102.
54. 2A adenosine receptor. Chem Phys Lipids 2013;169:39-45.